BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9204233)

  • 1. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].
    Zwahr C; Voss P; Kistner G
    Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Sep; 155(5):349. PubMed ID: 1832734
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
    Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B
    Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Triple test: problem or enhancement of prenatal diagnosis].
    Rauskolb R; Engel W
    Z Geburtshilfe Neonatol; 1995; 199(3):91. PubMed ID: 7553260
    [No Abstract]   [Full Text] [Related]  

  • 20. [Maternal serum screening for detection of fetal chromosome abnormalities].
    Holzgreve W; Miny P; Schloo R; Tercanli S
    Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.